D&B Business Directory
Roche Holding AG
Joint stock company Parent
Roche Holding AG
One of the world's largest pharmaceutical companies, Roche has operations in over 100 countries. Roche's prescription drugs include cancer therapies MabThera/Rituxan and Avastin, Perjeta and Kadcyla for HER2-positive breast cancer, idiopathic pulmonary fibrosis drug Esbriet, macular degeneration therapy Lucentis, and Tamiflu, which is used for infectious diseases. The company markets many of its bestsellers through California-based subsidiary Genentech ...
Read More
and Japanese affiliate Chugai Pharmaceutical. Roche generates majority of sales from North America.
Read Less
Severin Anton Schwan   See more contacts
Business Support Services Other Investment Pools and Funds Other Financial Investment Activities Business services, nec Management investment, open-end
See All Industries
Investors, nec
See Fewer Industries
Grenzacherstrasse 124 Basel, BASEL-STADT, 4058 Switzerland See other locations
$63.87 billion
-5.11% 5.91% $94,328 DEC
1896 1995
Stay on top of your Business Credit File
Get full access to view your D&B business credit file now for just $39/month!
View D&B Scores & Ratings
Get in Touch with 24 Principals*
A D&B Hoovers Subscription is your foot in the door to Roche Holding AG contact information.
  • Severin Anton Schwan
    Managing Director and Member of the Board of Directors and Authorised Signatory
  • Christoph Franz
    Chairman of the Board
  • Andreas Hoffmann
    Vice Chairman of the Board
  • Claudia Süssmuth
    Member of the Board of Directors
D&B Hoovers Logo

Dynamic search and list-building capabilities

Real-time trigger alerts

Comprehensive company profiles

Valuable research and technology reports

Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2020 (12 month period) in USD
Annual Revenue 2020
$63.87 billion USD
1 USD = 0.9132 CHF